SEARCH

SEARCH BY CITATION

References

  • 1
    Willan, A.R. and Briggs, A.H. (2006) Statistical Analysis of Cost-Effectiveness Data. Chichester : Wiley.
  • 2
    Connock, M., Round, J., Bayliss, S., Tubeuf, S., Greenheld, W. and Moore, D. (2009) Sorafenib for advanced heptacellular carcinoma. West Midlands Health Technology Assessment Evidence Review Group Report for the National Institute for Health and Clinical Excellence.
  • 3
    Walker, S., Palmer, S., Sculpher, M. (2007) The role of NICE technology appraisal in NHS rationing. British Medical Bulletin, 81–82, 5164.
  • 4
    ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet, ii 8607, 349360.
  • 5
    Meads, C., Salas, C., Roberts, T., Moore, D., Fry-Smith, A. and Hyde, C. (2002) Clinical effectiveness and cost utility of photodynamic therapy for wet age-related macular degeneration. West Midlands Health Technology Assessment Group Report for National Institute for Health and Clinical Excellence.